Deepa Jeyakumar, MD, from UC Irvine Health For Multiple Myeloma Research joins us at MOASCs Spotlight On® Hematology in Huntington Beach to discuss the toxicities with IDH1 & IDH2 inhibitors and a new side-effect the IDH differentiation syndrome.
Toxicities with IDH1 & IDH2 Inhibitors – IDH Differentiation Syndrome is a new side-effect
